{"entity": "journal", "iuid": "703c9d86969540ac974cfeb0fb18ef61", "timestamp": "2026-11-08T08:16:47.716Z", "links": {"self": {"href": "https://publications.scilifelab.se/journal/Life%20%28Basel%29.json"}, "display": {"href": "https://publications.scilifelab.se/journal/Life%20%28Basel%29"}}, "title": "Life (Basel)", "issn": "2075-1729", "issn-l": null, "publications_count": 2, "publications": [{"entity": "publication", "iuid": "6f6a5bd19f4d4a459ee0ff3a82fc3eef", "links": {"self": {"href": "https://publications.scilifelab.se/publication/6f6a5bd19f4d4a459ee0ff3a82fc3eef.json"}, "display": {"href": "https://publications.scilifelab.se/publication/6f6a5bd19f4d4a459ee0ff3a82fc3eef"}}, "title": "Resolving the Haplotype Complexity of Colorectal Cancer Genomes with Droplet Barcode Sequencing.", "authors": [{"family": "Siga", "given": "Humam", "initials": "H", "orcid": "0000-0003-1842-0882", "researcher": {"href": "https://publications.scilifelab.se/researcher/058b6ec6390a41929dc1288f71de63d4.json"}}, {"family": "H\u00f6jer", "given": "Pontus", "initials": "P", "orcid": "0000-0001-8010-4755", "researcher": {"href": "https://publications.scilifelab.se/researcher/13f901467fc54bb3a162e533248ebb70.json"}}, {"family": "Pourbozorgi", "given": "Parham", "initials": "P", "orcid": "0000-0002-5957-627X", "researcher": {"href": "https://publications.scilifelab.se/researcher/520886f23ef54f008bff773ebb86f7b1.json"}}, {"family": "Aghelpasand", "given": "Hooman", "initials": "H"}, {"family": "K\u00e4ller", "given": "Max", "initials": "M"}, {"family": "Hartman", "given": "Johan", "initials": "J", "orcid": "0000-0002-6500-8527", "researcher": {"href": "https://publications.scilifelab.se/researcher/da7cefda6e00463d8ba95fc63eeb8f0a.json"}}, {"family": "Williams", "given": "Cecilia", "initials": "C", "orcid": "0000-0002-0602-2062", "researcher": {"href": "https://publications.scilifelab.se/researcher/89989da8d4e64dd3a30b87fc62ceefae.json"}}, {"family": "Ahmadian", "given": "Afshin", "initials": "A"}], "type": "journal article", "published": "2026-05-22", "journal": {"title": "Life (Basel)", "issn": "2075-1729", "volume": "16", "issue": "6", "issn-l": null}, "abstract": "Precision medicine is increasingly applied in the cancer clinic, adapting treatment to genomic alterations of the tumor. However, whether alterations disrupt the function of a protein can depend on if both alleles of a gene are altered. While massively parallel sequencing technologies can identify sequence aberrations, they are limited in resolving the corresponding haplotype information. In this proof-of-concept case study, we applied the linked-read droplet barcode sequencing (DBS) technology to resolve the haplotype complexity of colorectal cancer genomes on paired tumor and normal samples. Several cancer-related genes carried multiple mutations in either one or both haplotypes. Additionally, a number of haplotype-resolved large structural variants and copy number alterations were detected and phased with short somatic variants. Nearly all characterized oncogenic pathways harbored some of the identified short somatic variants. The study demonstrates that linked-read DBS technology can characterize complex genetic variations in a haplotype context and may provide essential information for personalized approaches.", "doi": "10.3390/life16060874", "pmid": "42355402", "labels": {"NGI Stockholm (Genomics Production)": "Service", "NGI Short read": "Service", "NGI Stockholm (Genomics Applications)": "Collaborative", "NGI Other": "Service", "National Genomics Infrastructure": "Service"}, "xrefs": [{"db": "pii", "key": "life16060874"}, {"db": "pmc", "key": "PMC13301505"}], "notes": [], "created": "2026-07-14T17:34:48.527Z", "modified": "2026-07-14T17:34:48.921Z"}, {"entity": "publication", "iuid": "c6aa9463b9d146c5b285245971ccfc44", "links": {"self": {"href": "https://publications.scilifelab.se/publication/c6aa9463b9d146c5b285245971ccfc44.json"}, "display": {"href": "https://publications.scilifelab.se/publication/c6aa9463b9d146c5b285245971ccfc44"}}, "title": "Treatment of Metastatic Melanoma at First Diagnosis: Review of the Literature.", "authors": [{"family": "Berciano-Guerrero", "given": "Miguel-Angel", "initials": "MA", "orcid": "0000-0002-5437-5196", "researcher": {"href": "https://publications.scilifelab.se/researcher/4d4dad0bbcc6438982dea3413268994e.json"}}, {"family": "Guardamagna", "given": "Mora", "initials": "M"}, {"family": "Perez-Ruiz", "given": "Elisabeth", "initials": "E", "orcid": "0000-0001-7204-0800", "researcher": {"href": "https://publications.scilifelab.se/researcher/ea96e2b1045d4b338bf7e4055630af74.json"}}, {"family": "Jurado", "given": "Jose-Miguel", "initials": "JM"}, {"family": "Barrag\u00e1n", "given": "Isabel", "initials": "I", "orcid": "0000-0002-8586-6502", "researcher": {"href": "https://publications.scilifelab.se/researcher/b21619a3feff43a2bc28b5834c825d0c.json"}}, {"family": "Rueda-Dominguez", "given": "Antonio", "initials": "A"}], "type": "journal article", "published": "2022-08-24", "journal": {"title": "Life (Basel)", "issn": "2075-1729", "volume": "12", "issue": "9", "issn-l": null}, "abstract": "Metastatic melanoma (MM) is a pathological entity with a very poor prognosis that, until a few decades ago, had a low response rate to systemic treatments. Fortunately, in the last few years, new therapies for metastatic melanoma have emerged. Currently, targeted therapy and immunotherapy are the mainstays of the therapeutic arsenal available for patients with unresectable or metastatic melanoma. However, both clinical evolution and drug efficacy in melanoma patients are very different depending on the stage at which it is diagnosed. In fact, the aggressiveness of melanoma is different depending on whether it debuts directly as metastatic disease or if what occurs is a relapse after a first diagnosis at an early stage, although the biological determinants are largely unknown. Another key aspect in the clinical management of metastatic melanoma at first diagnosis strives in the different prognosis of melanoma of unknown primary (MUP) compared to melanoma of known primary (MPK). Understanding the mechanisms behind this, and the repercussion of implementing targeted and immune therapies in this specific form is crucial for designing diagnosis and treatment decision algorithms that optimize the current strategies. In this review article, we recapitulate the information available thus far regarding the epidemiology and response to immunotherapy treatments or targeted therapy in patients diagnosed with metastatic melanoma as a first diagnosis, with especial emphasis on the emerging specific information of the subpopulation formed by MUP patients.", "doi": "10.3390/life12091302", "pmid": "36143339", "labels": {"Bioinformatics Support for Computational Resources": "Service"}, "xrefs": [{"db": "pmc", "key": "PMC9505710"}, {"db": "pii", "key": "life12091302"}], "notes": [], "created": "2023-11-27T22:02:22.486Z", "modified": "2024-01-16T13:48:35.104Z"}], "created": "2023-11-27T22:02:22.558Z", "modified": "2023-11-27T22:02:22.558Z"}